Over 400,000 in Sarlahi to receive elephantiasis prevention drugs
Summary
Over 400,000 people in Sarlahi district will receive preventive medication against elephantiasis following an outbreak of lymphatic filariasis infections.
Key Points
- More than 400,000 people in Sarlahi will receive preventive drugs against elephantiasis.
- The campaign targets around 80% of the district's population across 12 local levels.
- Testing in October revealed 28 confirmed cases of lymphatic filariasis from 300 samples.
- The initiative is coordinated by the District Health Office, the Epidemiology and Disease Control Division, and the WHO.
